FDA investigates CT scan radiation overexposure risk
This article was originally published in The Gray Sheet
Executive Summary
FDA is conducting a safety investigation of CT brain perfusion scans performed at a single facility after learning of radiation overexposures at that location. Over an 18-month period, 206 patients at the facility received radiation doses at approximately eight times the appropriate level, in some cases resulting in hair loss and erythema, FDA says. While the event involved just one facility, "this situation may reflect more widespread problems with CT quality assurance programs and may not be isolated to this particular facility or this imaging procedure," the agency writes in an Oct. 8 initial safety notification. Hospitals and CT facilities should review CT protocols and carefully monitor radiation dose indices before and after scans, FDA says
You may also be interested in...
FDA Investigates CT Radiation Overdose In Multiple States, Facilities
FDA is investigating hundreds of cases of radiation overexposure from computed tomography (CT) imaging scans to determine whether the overdoses were caused by human error or a problem with the devices
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.